PembrolizumabChronic lymphocytic immune-mediated colitis: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1885卷 / 1期
关键词：
D O I：
10.1007/s40278-021-07196-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：437 / 437
相关论文
共 50 条
  • [41] Metachronous Esophageal Ulcers after Immune-mediated Colitis Due to Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review
    Ogawa, Soichiro
    Kawakami, Hiroshi
    Suzuki, Sho
    Kuroki, Daisuke
    Uchiyama, Naomi
    Hatada, Hiroshi
    Gi, Toshihiro
    Sato, Yuichiro
    INTERNAL MEDICINE, 2021, 60 (17) : 2783 - 2791
  • [42] Immune-mediated colitis after immune checkpoint inhibitor therapy
    Giesler, Sophie
    Riemer, Roxane
    Lowinus, Theresa
    Zeiser, Robert
    TRENDS IN MOLECULAR MEDICINE, 2025, 31 (03) : 265 - 280
  • [43] A Case of Immune-Mediated Pneumonitis?
    Felizardo, Margarida
    Matos, Claudia P.
    Furtado, Sofia T.
    Teixeira, Encarnacao
    Coelho, Jose P.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S239 - S240
  • [44] Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report
    Woo, Hyun Sun
    Lee, Kyoung Hwa
    Yoon, Phill Hoon
    Kim, Su Ji
    Park, Inkeun
    Kim, Young Saing
    Ahn, Hee Kyung
    Hong, Junshik
    Shin, Dong Bok
    Sym, Sun Jin
    CANCER RESEARCH AND TREATMENT, 2015, 47 (04): : 949 - 953
  • [45] Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
    Pan, Elizabeth
    Hsieh, Eric
    Piatek, Caroline
    CASE REPORTS IN ONCOLOGY, 2018, 11 (03): : 880 - 882
  • [46] TozinameranRelapse of immune-mediated thrombotic thrombocytopenic purpura: case report
    Reactions Weekly, 2022, 1897 (1) : 342 - 342
  • [47] Dermatomyositis or immune-mediated necrotizing myopathy an interesting case report
    Teege, Sophie
    Haag, Friedrich
    INTERNIST, 2018, 59 : S38 - S38
  • [48] TozinameranAcquired immune-mediated thrombotic thrombocytopenic purpura: case report
    Reactions Weekly, 2022, 1891 (1) : 272 - 272
  • [49] Nivolumab/pazopanibLiver toxicity and immune-mediated rash: case report
    Reactions Weekly, 2021, 1861 (1) : 255 - 255
  • [50] Atezolizumab/bevacizumabSevere encephalitis and immune-mediated polyradiculoneuropathy: case report
    Reactions Weekly, 2021, 1865 (1) : 85 - 85
12345